Literature DB >> 10162421

Modelling valuations for health states: the effect of duration.

P Dolan1.   

Abstract

An important issue which has been raised in the measurement of health status is the effect that the time spent in a health state may have on the way that state is perceived. Recently a set of valuations for health states defined in terms of the EuroQol Descriptive System was generated from a study of over 3000 members of the UK general public. The valuations were elicited using the visual analogue scale (VAS) and time trade-off (TTO) methods and were for states that lasted for 10 years. Using VAS valuations for states lasting 1 month, 1 year and 10 years derived from a subset of respondents to the general population study, this paper presents valuation "tariffs" for all EuroQol states based on the different durations. The results support those of previous studies which suggest that poor states of health become more intolerable the longer they last. Such findings suggest that the results of studies in which the value given to a health state is assumed to be linearly related to the time spent in that health state should be treated with caution and subjected to sensitivity analysis over an appropriate range of values.

Mesh:

Year:  1996        PMID: 10162421     DOI: 10.1016/0168-8510(96)00853-6

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  35 in total

1.  Chained time trade-off and standard gamble methods. Applications in oesophageal cancer.

Authors:  Paul McNamee; Sharon Glendinning; Jonathan Shenfine; Nick Steen; S Michael Griffin; John Bond
Journal:  Eur J Health Econ       Date:  2004-02

2.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

3.  What Preoperative Factors are Associated With Not Achieving a Minimum Clinically Important Difference After THA? Findings from an International Multicenter Study.

Authors:  Pakdee Rojanasopondist; Vincent P Galea; James W Connelly; Sean J Matuszak; Ola Rolfson; Charles R Bragdon; Henrik Malchau
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

4.  Health-related quality of life assessment by the EuroQol-5D can provide cost-utility data in the field of low-back surgery.

Authors:  Tore K Solberg; Jan-Abel Olsen; Tor Ingebrigtsen; Dag Hofoss; Oystein P Nygaard
Journal:  Eur Spine J       Date:  2005-04-21       Impact factor: 3.134

Review 5.  Health related quality of life outcome instruments.

Authors:  Gunnar Németh
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

Review 6.  Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research.

Authors:  Patricia Cubi-Molla; Koonal Shah; Kristina Burström
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

7.  How should different life expectancies be valued?

Authors:  N Waugh; D Scott
Journal:  BMJ       Date:  1998-04-25

8.  Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task.

Authors:  Richard Norman; Madeleine T King; Dushyant Clarke; Rosalie Viney; Paula Cronin; Deborah Street
Journal:  Qual Life Res       Date:  2010-02-22       Impact factor: 4.147

Review 9.  Using QALYs in cancer: a review of the methodological limitations.

Authors:  Martina Garau; Koonal K Shah; Anne R Mason; Qing Wang; Adrian Towse; Michael F Drummond
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

10.  The duration effect: a link between TTO and VAS values.

Authors:  Benjamin M Craig
Journal:  Health Econ       Date:  2009-02       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.